{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T19:31:33Z","timestamp":1781033493963,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jamda.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jamda.2017.09.023","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T16:16:46Z","timestamp":1510157806000},"page":"342-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Renin-Angiotensin System Blockers and Statins Are Associated With Lower In-Hospital Mortality in Very Elderly Hypertensives"],"prefix":"10.1016","volume":"19","author":[{"given":"Francesco","family":"Spannella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Giulietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Balietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Cocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Landi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Elena","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Borioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Rosettani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bordoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Sarzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2017.09.023_bib1","unstructured":"Italy: WHO statistical profile. Country statistics and global health estimates by WHO and UN partners. Last updated: January\u00a02015."},{"key":"10.1016\/j.jamda.2017.09.023_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrcardio.2010.162","article-title":"Cardiovascular drug therapy in the elderly: Benefits and challenges","volume":"8","author":"Fleg","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jamda.2017.09.023_bib3","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/HYPERTENSIONAHA.108.113357","article-title":"Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004","volume":"52","author":"Cutler","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.jamda.2017.09.023_bib4","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jamda.2017.09.023_bib5","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2017.09.023_bib6","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2016.7050","article-title":"Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged \u226575 years: A randomized clinical trial","volume":"315","author":"Williamson","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2017.09.023_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/HYPERTENSIONAHA.117.09689","article-title":"Hypertension, its treatment, frailty, falls, and mortality","volume":"70","author":"Bursztyn","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.jamda.2017.09.023_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1077558710379422","article-title":"Emergency department use by older adults: A literature review on trends, appropriateness, and consequences of unmet health care needs","volume":"68","author":"Gruneir","year":"2011","journal-title":"Med Care Res Rev"},{"key":"10.1016\/j.jamda.2017.09.023_bib9","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"3 suppl","key":"10.1016\/j.jamda.2017.09.023_bib10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjcard.2007.11.011","article-title":"An international consensus statement regarding amino-terminal pro-B-type natriuretic peptide testing: The International NT-proBNP Consensus Panel","volume":"101","author":"Januzzi","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jamda.2017.09.023_bib11","doi-asserted-by":"crossref","first-page":"M546","DOI":"10.1093\/gerona\/54.11.M546","article-title":"Scaling ADLs within the MDS","volume":"54","author":"Morris","year":"1999","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jamda.2017.09.023_bib12","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1046\/j.1532-5415.2003.51465.x","article-title":"The Mini-Cog as a screen for dementia: Validation in a population-based sample","volume":"51","author":"Borson","year":"2003","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2017.09.023_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ageing\/31.4.277","article-title":"Geriatric Index of Comorbidity: Validation and comparison with other measures of comorbidity","volume":"31","author":"Rozzini","year":"2002","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2017.09.023_bib14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/SMJ.0b013e31825fed90","article-title":"Pharmacotherapy considerations in elderly adults","volume":"105","author":"Wooten","year":"2012","journal-title":"South Med J"},{"key":"10.1016\/j.jamda.2017.09.023_bib15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF03324803","article-title":"Quality of care in congestive heart failure in the elderly: Epidemiological evidence of a gap between guidelines and clinical practice","volume":"22","author":"Brocco","year":"2010","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jamda.2017.09.023_bib16","doi-asserted-by":"crossref","first-page":"h4984","DOI":"10.1136\/bmj.h4984","article-title":"Association between guideline recommended drugs and death in older adults with multiple chronic conditions: Population based cohort study","volume":"351","author":"Tinetti","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2017.09.023_bib17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1532-5415.2003.51163.x","article-title":"Predictive factors of in-hospital mortality in older patients admitted to a medical intensive care unit","volume":"51","author":"Bo","year":"2003","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2017.09.023_bib18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jamda.2013.10.013","article-title":"Cardiac and inflammatory biomarkers and in-hospital mortality in older medical patients","volume":"15","author":"Comba","year":"2014","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2017.09.023_bib19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.archger.2008.03.011","article-title":"Inflammation and disability as risk factors for mortality in elderly acute care patients","volume":"48","author":"Forasassi","year":"2009","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.jamda.2017.09.023_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ajh.23598","article-title":"Evaluation and management of anemia in the elderly","volume":"89","author":"Goodnough","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jamda.2017.09.023_bib21","doi-asserted-by":"crossref","first-page":"e77929","DOI":"10.1371\/journal.pone.0077929","article-title":"In nonagenarians, acute kidney injury predicts in-hospital mortality, while heart failure predicts hospital length of stay","volume":"8","author":"Chao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jamda.2017.09.023_bib22","doi-asserted-by":"crossref","first-page":"e0153759","DOI":"10.1371\/journal.pone.0153759","article-title":"NT-proBNP and its correlation with in-hospital mortality in the very elderly without an admission diagnosis of heart failure","volume":"11","author":"Sarzani","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jamda.2017.09.023_bib23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ahj.2013.01.007","article-title":"Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation","volume":"165","author":"Bui","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jamda.2017.09.023_bib24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/HYPERTENSIONAHA.116.09390","article-title":"Blood pressure, antihypertensive polypharmacy, frailty, and risk for serious fall injuries among older treated adults with hypertension","volume":"70","author":"Bromfield","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.jamda.2017.09.023_bib25","doi-asserted-by":"crossref","first-page":"277.e13","DOI":"10.1016\/j.jamda.2016.12.076","article-title":"Hypertension and its treatment at age 90 years: Is there an association with 5-year mortality?","volume":"18","author":"Stessman","year":"2017","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2017.09.023_bib26","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/HYPERTENSIONAHA.115.07020","article-title":"An expert opinion from the European Society of Hypertension-European Union Geriatric Medicine Society Working Group on the management of hypertension in very old, frail subjects","volume":"67","author":"Benetos","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jamda.2017.09.023_bib27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/gerona\/glv228","article-title":"Characterizing frailty status in the Systolic Blood Pressure Intervention Trial","volume":"71","author":"Pajewski","year":"2016","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jamda.2017.09.023_bib28","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2013.184182","article-title":"Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries","volume":"310","author":"Chow","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2017.09.023_bib29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3724\/SP.J.1263.2011.12031","article-title":"Cardiovascular and cerebrovascular outcomes in elderly hypertensive patients treated with either ARB or ACEI","volume":"9","author":"Ma","year":"2012","journal-title":"J\u00a0Geriatr Cardiol"},{"key":"10.1016\/j.jamda.2017.09.023_bib30","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1093\/eurheartj\/ehs075","article-title":"Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: A meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients","volume":"33","author":"Van Vark","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jamda.2017.09.023_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mayocp.2015.10.019","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in patients without heart failure? Insights from 254,301 patients from randomized trials","volume":"91","author":"Bangalore","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jamda.2017.09.023_bib32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.pcad.2015.11.004","article-title":"The divergent cardiovascular effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on myocardial infarction and death","volume":"58","author":"Strauss","year":"2016","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jamda.2017.09.023_bib33","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1161\/CIR.0b013e31821daaf6","article-title":"ACCF\/AHA 2011 expert consensus document on hypertension in the elderly: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents","volume":"123","author":"Aronow","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jamda.2017.09.023_bib34","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.2215\/CJN.08611209","article-title":"Renin-angiotensin-aldosterone system blockade effects on the kidney in the elderly: Benefits and limitations","volume":"5","author":"Turgut","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jamda.2017.09.023_bib35","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1751-7176.2009.00147.x","article-title":"The effects of an olmesartan medoxomil-based treatment algorithm on 24-hour blood pressure levels in elderly patients aged 65 and older","volume":"11","author":"Kereiakes","year":"2009","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jamda.2017.09.023_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-151-1-200907070-00122","article-title":"Effect of telmisartan on renal outcomes: A randomized trial","volume":"151","author":"Mann","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jamda.2017.09.023_bib37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40292-013-0027-y","article-title":"Antihypertensive treatment and renal protection: The role of drugs inhibiting the renin-angiotensin-aldosterone system","volume":"20","author":"Viazzi","year":"2013","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.jamda.2017.09.023_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40292-017-0196-1","article-title":"Cardiac natriuretic peptides, hypertension and cardiovascular risk","volume":"24","author":"Sarzani","year":"2017","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.jamda.2017.09.023_bib39","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/jhh.2008.171","article-title":"Protective effects of renin-angiotensin blockade beyond blood pressure control","volume":"23","author":"Mancia","year":"2009","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.jamda.2017.09.023_bib40","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1097\/HJH.0000000000001438","article-title":"Plasma renin activity to plasma aldosterone concentration ratio correlates with night-time and pulse pressures in essential hypertensive patients treated with angiotensin-converting enzyme inhibitors\/AT1 blockers","volume":"35","author":"Spannella","year":"2017","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jamda.2017.09.023_bib41","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jamda.2017.09.023_bib42","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2017.09.023_bib43","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-152-8-201004200-00005","article-title":"Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: Exploratory analysis of a randomized trial","volume":"152","author":"Glynn","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jamda.2017.09.023_bib44","first-page":"431","article-title":"Statins for primary cardiovascular prevention in the elderly","volume":"12","author":"Pedro-Botet","year":"2015","journal-title":"J\u00a0Geriatr Cardiol"},{"key":"10.1016\/j.jamda.2017.09.023_bib45","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/j.jacc.2013.07.069","article-title":"Benefits of statins in elderly subjects without established cardiovascular disease: A meta-analysis","volume":"62","author":"Savarese","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jamda.2017.09.023_bib46","doi-asserted-by":"crossref","first-page":"e000127","DOI":"10.1136\/openhrt-2014-000127","article-title":"Benefit of statin pretreatment in prevention of contrast-induced nephropathy in different adult patient population: Systematic review and meta-analysis","volume":"1","author":"Singh","year":"2014","journal-title":"Open Heart"},{"key":"10.1016\/j.jamda.2017.09.023_bib47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0195-668X(02)00419-0","article-title":"Statin effects beyond lipid lowering\u2014are they clinically relevant?","volume":"24","author":"Bonetti","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jamda.2017.09.023_bib48","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1161\/CIRCULATIONAHA.105.591446","article-title":"Statins and mortality among elderly patients hospitalized with heart failure","volume":"113","author":"Foody","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jamda.2017.09.023_bib49","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jacc.2003.07.049","article-title":"Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure","volume":"43","author":"Horwich","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jamda.2017.09.023_bib50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00134-005-2859-y","article-title":"Statin therapy is associated with fewer deaths in patients with bacteraemia","volume":"32","author":"Kruger","year":"2006","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jamda.2017.09.023_bib51","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0163-7258(03)00055-X","article-title":"The lipid and non-lipid effects of statins","volume":"99","author":"Wierzbicki","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jamda.2017.09.023_bib52","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(98)05917-0","article-title":"Inhibition of proinflammatory cytokine production by pravastatin","volume":"353","author":"Rosenson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2017.09.023_bib53","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0167-5273(00)00439-3","article-title":"Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia","volume":"77","author":"Musial","year":"2001","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jamda.2017.09.023_bib54","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1465-9921-6-82","article-title":"The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia","volume":"6","author":"Mortensen","year":"2005","journal-title":"Respir Res"},{"key":"10.1016\/j.jamda.2017.09.023_bib55","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1086\/323334","article-title":"The effect of statins on mortality in patients with bacteremia","volume":"33","author":"Liappis","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jamda.2017.09.023_bib56","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/HYPERTENSIONAHA.116.08600","article-title":"On-treatment blood pressure and cardiovascular outcomes in older adults with isolated systolic hypertension","volume":"69","author":"Yano","year":"2017","journal-title":"Hypertension"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861017305467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861017305467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T05:51:08Z","timestamp":1535262668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861017305467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1525861017305467"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2017.09.023","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renin-Angiotensin System Blockers and Statins Are Associated With Lower In-Hospital Mortality in Very Elderly Hypertensives","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2017.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}